Review of Cardiac Resynchronization Therapy

0:00-19:57

Heart failure (HF) affects more than 64 million individuals worldwide, and 20% to 30% of patients with HF and systolic dysfunction have cardiac dyssynchrony due to conduction system disease. JAMA Review author Mihail Chelu, MD, PhD, of Baylor College of Medicine discusses cardiac resynchronization therapy with JAMA Associate Editor David Simel, MD, MHS. Related Content: Cardiac Resynchronization Therapy Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure

Publisher

JAMA Clinical Reviews

Link

edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2026.5869

Published

April 27, 2026

Duration

20 min

Format

Podcast

Category

Lifestyle · Medicine

Source

RSS feed

Host

JAMA Network

JC

JAMA Clinical Reviews

@jamaclinicalreviews

#cardiacresynchronizationtherapy #medicine

The Nile